Personalized Treatment Optimization for Chronic Pain with Dr. Ruslan Dorfman скачать в хорошем качестве

Personalized Treatment Optimization for Chronic Pain with Dr. Ruslan Dorfman

Patients suffering from chronic pain are frequently treated with opioids, antidepressants, antiepileptic drugs and anti-anxiety medications. However, response to these medications is highly variable. Many patients do not experience adequate pain control with opioids leading to increased opioids consumption, and raising concerns about drug dependence or abuse. Clinical response to antidepressants and opioids, as well as the risk of adverse side effects and addiction, is dependent on a patient’s inherent ability to metabolize these medications. Dr. Ruslan Dorfman will explain how pharmacogenetic testing can help patients and their healthcare providers to identify which medications are more likely to work and suggest safer drug doses. Dr. Dorfman is a founder and CEO of GeneYouIn Inc, agenetic testing company that has developed a proprietary genome analytics platform called PillCheckTM. Dr. Dorfman is a molecular geneticist by training, and is passionate about pharmacogenetics of chronic pain and genetics of rare diseases. Prior to founding GeneYouIn in 2012 he worked at Sick Kids Hospital, and developed the Personalized Medicine Strategy at the Mount Sinai Hospital. He has published more than 30 manuscripts on genetics of Cystic Fibrosis, disease modifying genes, and pain genetics. Dr. Dorfman has expertise in clinical study design, statistical analysis, pharmacogenetics, genomic annotation and healthcare strategy. Sign up for upcoming webinars here: https://www.painhq.org/connect/webinars